Core Laboratories Inc. (NYSE:CLB - Get Free Report)'s stock price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $16.08 and traded as high as $16.70. Core Laboratories shares last traded at $16.3410, with a volume of 247,066 shares trading hands.
Wall Street Analyst Weigh In
Separately, Weiss Ratings reiterated a "hold (c)" rating on shares of Core Laboratories in a report on Friday, March 27th. Four investment analysts have rated the stock with a Hold rating, According to MarketBeat, Core Laboratories currently has a consensus rating of "Hold" and a consensus target price of $12.50.
View Our Latest Report on CLB
Core Laboratories Stock Up 0.1%
The business's 50 day moving average price is $17.53 and its 200-day moving average price is $16.08. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.51 and a current ratio of 2.02. The firm has a market capitalization of $752.50 million, a PE ratio of 24.39, a P/E/G ratio of 14.25 and a beta of 1.15.
Core Laboratories (NYSE:CLB - Get Free Report) last posted its quarterly earnings data on Wednesday, February 4th. The oil and gas company reported $0.21 earnings per share for the quarter, topping analysts' consensus estimates of $0.20 by $0.01. The firm had revenue of $138.26 million during the quarter, compared to analysts' expectations of $130.40 million. Core Laboratories had a net margin of 6.04% and a return on equity of 12.18%. The firm's quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter last year, the company posted $0.22 EPS. Core Laboratories has set its Q1 2026 guidance at 0.110-0.150 EPS. As a group, equities research analysts forecast that Core Laboratories Inc. will post 0.96 earnings per share for the current year.
Core Laboratories Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Monday, March 9th. Stockholders of record on Monday, February 16th were paid a $0.01 dividend. The ex-dividend date of this dividend was Friday, February 13th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.2%. Core Laboratories's payout ratio is presently 5.97%.
Hedge Funds Weigh In On Core Laboratories
Hedge funds have recently bought and sold shares of the company. Ariel Investments LLC grew its position in Core Laboratories by 25.5% in the 2nd quarter. Ariel Investments LLC now owns 12,976,463 shares of the oil and gas company's stock valued at $149,489,000 after acquiring an additional 2,634,438 shares in the last quarter. CWA Asset Management Group LLC acquired a new stake in shares of Core Laboratories during the fourth quarter worth about $9,978,000. Goldman Sachs Group Inc. boosted its stake in shares of Core Laboratories by 185.0% in the fourth quarter. Goldman Sachs Group Inc. now owns 845,251 shares of the oil and gas company's stock valued at $13,549,000 after purchasing an additional 548,657 shares during the period. Disciplined Growth Investors Inc. MN grew its holdings in shares of Core Laboratories by 9.7% in the third quarter. Disciplined Growth Investors Inc. MN now owns 5,969,860 shares of the oil and gas company's stock valued at $73,787,000 after purchasing an additional 528,976 shares in the last quarter. Finally, MAC Alpha Capital Management LP purchased a new stake in Core Laboratories during the 4th quarter worth approximately $5,016,000. Institutional investors and hedge funds own 97.81% of the company's stock.
About Core Laboratories
(
Get Free Report)
Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.
The company's portfolio spans two primary service lines: reservoir description and production enhancement.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Core Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Core Laboratories wasn't on the list.
While Core Laboratories currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
